Dothan, ALABAMA2 Active Studies

NASH Clinical Trials in Dothan, ALABAMA

Find 2 actively recruiting nash clinical trials in Dothan, ALABAMA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,650
Enrolling

Recruiting NASH Studies in Dothan

About NASH Clinical Trials in Dothan

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 2 nash clinical trials recruiting participants in Dothan, ALABAMA. These studies are seeking a combined 2,650 participants. Research is being sponsored by Akero Therapeutics, Inc, Inventiva Pharma. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in Dothan — FAQ

Are there nash clinical trials in Dothan?

Yes, there are 2 nash clinical trials currently recruiting in Dothan, ALABAMA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dothan?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you about next steps.

Are clinical trials in Dothan free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dothan studies also compensate for your time and travel.

What nash treatments are being tested?

The 2 active trials in Dothan are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated March 2, 2026 from ClinicalTrials.gov